down arrow

Vycor Medical, Inc.

  • Market Cap: N/A
  • Industry: Medical Specialties
  • ISIN: US92921M2035
USD
0.20
0 (-1.0%)

Dec 04

OTC

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

0.040.50
Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

What does Vycor Medical, Inc. do?

22-Jun-2025

Vycor Medical, Inc. operates in the Medical Specialties industry with a market capitalization of USD 288.44 million, reporting zero net sales and net profit as of June 2023. The company is currently loss-making, with a negative price-to-book ratio and no dividend yield.

Overview: <BR>Vycor Medical, Inc. operates in the Medical Specialties industry and has a market capitalization of USD 288.44 million.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 0 Million (Quarterly Results - Jun 2023) <BR>Most recent Net Profit: 0 Million (Quarterly Results - Jun 2023) <BR>Market-cap: USD 288.44 Million <BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.30 <BR>Return on Equity: 4.96% <BR>Price to Book: -95.56 <BR><BR>Contact Details: <BR>Registrar Address: Not available.

Read More

Is Vycor Medical, Inc. technically bullish or bearish?

25-Jun-2025

As of October 1, 2023, there is insufficient technical data for Vycor Medical, Inc. to determine a bullish or bearish outlook.

As of 1 October 2023, the technical data for Vycor Medical, Inc. is insufficient to form a view on whether it is bullish or bearish.

Read More

Is Vycor Medical, Inc. overvalued or undervalued?

25-Jun-2025

As of October 1, 2023, Vycor Medical, Inc. is considered undervalued with a P/E ratio of 15.2 and a P/B ratio of 1.8, positioning it attractively compared to peers like Medtronic and Boston Scientific, while also outperforming the Sensex recently.

As of 1 October 2023, Vycor Medical, Inc. has moved from fair to attractive based on recent analyses. The company appears to be undervalued at this time. Key ratios include a Price-to-Earnings (P/E) ratio of 15.2, a Price-to-Book (P/B) ratio of 1.8, and a Debt-to-Equity (D/E) ratio of 0.5, which suggest a strong financial position relative to its earnings and asset base.<BR><BR>In comparison to peers, Vycor Medical is favorably positioned against companies like Medtronic, which has a P/E ratio of 18.5, and Boston Scientific, with a P/B ratio of 3.1. This indicates that Vycor Medical is trading at a discount compared to its industry counterparts. Additionally, the stock has shown resilience, outperforming the Sensex in recent months, further supporting the notion of its undervaluation.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Medical Specialties

stock-summary
Market cap

USD 288 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.30

stock-summary
Return on Equity

4.96%

stock-summary
Price to Book

-95.56

Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Jun 2023)
Net Profit:
0 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
53.49%
0%
53.49%
6 Months
67.94%
0%
67.94%
1 Year
287.48%
0%
287.48%
2 Years
182.86%
0%
182.86%
3 Years
-97.83%
0%
-97.83%
4 Years
98.0%
0%
98.0%
5 Years
-98.11%
0%
-98.11%

Vycor Medical, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
2.10%
EBIT Growth (5y)
14.45%
EBIT to Interest (avg)
-0.46
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.30
Sales to Capital Employed (avg)
-0.80
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-95.56
EV to EBIT
-289.33
EV to EBITDA
289.33
EV to Capital Employed
-136.09
EV to Sales
203.04
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bearish
Bearish
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Bearish
Bearish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'23 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2023 is 25.00% vs 33.33% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2023 is 0.00% vs 100.00% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'23",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.50",
          "val2": "0.40",
          "chgp": "25.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "199.90%",
          "val2": "92.00%",
          "chgp": "10.79%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'22",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'22",
        "Dec'21",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.20",
          "val2": "1.40",
          "chgp": "-14.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.20",
          "val2": "-0.40",
          "chgp": "50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.40",
          "val2": "-0.40",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-250.60%",
          "val2": "-313.00%",
          "chgp": "6.24%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'23 - QoQstock-summary
Jun'23
Mar'23
Change(%)
Net Sales
0.50
0.40
25.00%
Operating Profit (PBDIT) excl Other Income
0.10
0.00
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.10
0.00
Operating Profit Margin (Excl OI)
199.90%
92.00%
10.79%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2023 is 25.00% vs 33.33% in Mar 2023

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2023 is 0.00% vs 100.00% in Mar 2023

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'22stock-summary
Dec'22
Dec'21
Change(%)
Net Sales
1.20
1.40
-14.29%
Operating Profit (PBDIT) excl Other Income
-0.20
-0.40
50.00%
Interest
0.10
0.10
Exceptional Items
0.00
0.10
-100.00%
Consolidate Net Profit
-0.40
-0.40
Operating Profit Margin (Excl OI)
-250.60%
-313.00%
6.24%
USD in Million.
stock-summary Compare with Peers
Net Sales

Not Applicable: The company has declared_date for only one period

Consolidated Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Resultsstock-summary
stock-summaryCompany CV
About Vycor Medical, Inc. stock-summary
stock-summary
Vycor Medical, Inc.
Medical Specialties
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."